ScholarMate
English简体中文繁體中文
客服熱線:400-1616-289
登入註冊
期刊論文

Identification of a cellular senescence-related-lncRNA (SRlncRNA) signature to predict the overall survival of glioma patients and the tumor immune microenvironment

Liu, Qing; Bao, Hongbo; Zhang, Sibin; Song, Tianjun; Li, Chenlong; Sun, Guiyin; Sun, Xiaoyang; Fu, Tianjiao; Wang, Yujie; Liang, Peng*哈尔滨医科大学
Frontiers in Genetics2023-2-24DOI: 10.3389/fgene.2023.1096792
2閱讀
引用收藏
分享

摘要

Background: Gliomas are brain tumors that arise from glial cells, and they are the most common primary intracranial tumors with a poor prognosis. Cellular senescence plays a critical role in cancer, especially in glioma. In this study, we constructed a senescence-related lncRNA (SRlncRNA) signature to assess the prognosis of glioma.Methods: The Cancer Genome Atlas was used to collect SRlncRNA transcriptome profiles and clinical data about glioma. Patients were randomized to training, testing, and whole cohorts. LASSO and Cox regression analyses were employed to construct the SRlncRNA signature, and Kaplan-Meier (K-M) analysis was performed to determine each cohort's survival. Receiver operating characteristic (ROC) curves were applied to verify the accuracy of this signature. Gene set enrichment analysis was used to visualize functional enrichment (GSEA). The CIBERSORT algorithm, ESTIMATE and TIMER databases were utilized to evaluate the differences in the infiltration of 22 types of immune cells and their association with the signature. RT-qPCR and IHC were used to identify the consistency of the signature in tumor tissue.Results: An SRlncRNA signature consisting of six long non-coding RNAs (lncRNAs) was constructed, and patients were divided into high-risk and low-risk groups by the median of their riskscore. The KM analysis showed that the high-risk group had worse overall survival, and the ROC curve confirmed that the riskscore had more accurate predictive power. A multivariate Cox analysis and its scatter plot with clinical characteristics confirmed the riskscore as an independent risk factor for overall survival. GSEA showed that the GO and KEGG pathways were mainly enriched in the immune response to tumor cells, p53 signaling pathway, mTOR signaling pathway, and Wnt signaling pathway. Further validation also yielded significant differences in the risk signature in terms of immune cell infiltration, which may be closely related to prognostic differences, and qRT-PCR and IHC confirmed the consistency of the expression differences in the major lncRNAs with those in the prediction model.Conclusion Our findings indicated that the SRlncRNA signature might be used as a predictive biomarker and that there is a link between it and immune infiltration. This discovery is consistent with the present categorization system and may open new avenues for research and personalized therapy.

學科與關鍵詞

關鍵詞
cellular senescencegliomalong non-coding RNAprognostic signatureoverall survivalimmune microenvironment
相關
載入中…
  • Construction and Verification of a Novel Pyroptosis-Related lncRNA Signature Associated with Immune Landscape in Gliomas
    Feng, Xiaoqiang; Chen, Yuehua; Liu, Xuanyu; Zhong, Zhihui; Liu, Yanjun*Journal of Oncology, 2022, 2022: 7043431.
  • Comprehensive analysis: Necroptosis-related lncRNAs can effectively predict the prognosis of glioma patients
    Chen, Desheng; Dou, Chao; Liu, Haiyu; Xu, Binshun; Hu, Bowen; Kuang, Liangwen; Yao, Jiawei; Zhao, Yan; Yu, Shan; Li, Yang; Wang, Fuqing*; Guo, Mian*Frontiers in Oncology, 2022, 12: 929233.被引 4
  • A TGF-β signaling-related lncRNA signature for prediction of glioma prognosis, immune microenvironment, and immunotherapy response
    Duan, Wei-Wei; Yang, Li-Ting; Liu, Jian; Dai, Zi-Yu; Wang, Ze-Yu; Zhang, Hao; Zhang, Xun; Liang, Xi-Song; Luo, Peng; Zhang, Jian; Liu, Zao-Qu; Zhang, Nan; Mo, Hao-Yang; Qu, Chun-Run; Xia, Zhi-Wei*; Cheng, Quan*CNS Neuroscience & Therapeutics, 2023.
查看全部 →

發表資訊

論文狀態
公開發表
期刊
Frontiers in Genetics
發表日期
2023-02-24
卷期
第 14 卷
頁碼
1096792
DOI
10.3389/fgene.2023.1096792
成果收錄
SCIE

作者

  • L

    Liu, Qing (第一作者)

    harbin med univ

  • B

    Bao, Hongbo

    harbin med univ

查看全部 10 位作者收起作者
  • Z

    Zhang, Sibin

    harbin med univ

  • S

    Song, Tianjun

    2

  • L

    Li, Chenlong

    harbin med univ

  • S

    Sun, Guiyin

    harbin med univ

  • S

    Sun, Xiaoyang

    harbin med univ

  • F

    Fu, Tianjiao

    harbin med univ

  • W

    Wang, Yujie

    harbin med univ

  • L

    Liang, Peng (通訊)

    harbin med univ

登入解鎖更多功能

  • 收藏這篇,隨時在「我的 · 收藏」找回
  • 認領你的成果,生成推廣素材
  • 關注作者獲取最新成果
  • 加入項目組、協同寫作
註冊 / 登入

產品服務

  • 科研之友
  • 創新城
  • 科創雲

服務支援

  • 幫助中心
  • 隱私政策
  • 服務條款

聯絡方式

線上客服:【】
客服熱線:400-1616-289
電子郵件:support@scholarmate.com

關注或下載科研之友

微信 QR Code
微信公眾號
客戶端下載 QR Code
下載客戶端
科研成果科研人員科研機構科研動態愛瑞思軟件

©2026 深圳市科研之友网络服务有限公司

公安備案圖示粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417